Study on global R&D of anti-coronavirus 3CL protease inhibitors based on patent analysis.
Chinese Journal of New Drugs
; 32(1):1-7, 2023.
Article
in Chinese
| EMBASE | ID: covidwho-2297220
ABSTRACT
3CL protease inhibitors has become the focus of the current research on anti-coronavirus drugs. The analysis of the patent information will help the research and innovation of such anti-coronavirus drugs. This paper analyzes the application trends of anti-coronavirus 3CL protease inhibitor-related patents, the distribution of regional status of patents, important applicants, patented technology themes, progress of key drug development and other factors. We also analyze the development of related patent technologies and aim to help domestic pharmaceutical enterprises carry out innovation and complete the strategic layout.Copyright © 2023 Chinese Journal of New Drugs Co. Ltd.. All rights reserved.
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Language:
Chinese
Journal:
Chinese Journal of New Drugs
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS